TD Securities analyst Derek Lessard downgrades Jamieson Wellness (TSX:JWEL) from Buy to Action List Buy and announces C$50 price target.
Many Bed Bath & Beyond Shelves Empty For Holiday Shopping: Report
A recent study by DataWeave Inc. reveals that more than 40% of Bed Bath & Beyond's products were out of stock in October, which is close to twice the level in the first half of 2022.
